Tuesday, June 3, 2025

Stryker launches national direct-to-patient marketing campaign

Related stories

EXL & Databricks launch GenAI tool for code migration

EXL, a leading data and AI-driven company, has deepened...

Aptean Acquisition of VLEX for DACH ERP Reach

Aptean Inc., a global leader in AI-powered enterprise resource...

Portless Raises $18M to Transform Global E-Com & Fulfillment

Portless, a U.S.-based innovator in global e-commerce fulfillment, announced...

Syneris Launches to Disrupt AI with Decentralized Compute

A unified network leveraging underused GPU and CPU resources...

Tenable to Acquire Apex Security to Boost AI Risk Coverage

Tenable Holdings, Inc., the exposure management company, announced its intent...
spot_imgspot_img

Stryker, one of the world’s largest medical technology companies, announced the launch of a nationwide, direct-to-patient marketing campaign, “Scan. Plan. Mako Can.” Through this campaign, Stryker aims to continue to drive patient awareness of Mako SmartRobotics, an innovative option for those needing joint replacement surgery due to arthritis of the knee or hip.

“‘Scan. Plan. Mako Can.’ is rooted in the foundation of Mako SmartRobotics™,” said Don Payerle, president of Stryker’s Joint Replacement division. “We have an unwavering commitment to revolutionizing joint replacement technology and enabling surgeons to achieve enhanced outcomes for their patients. We are eager to share this campaign with patients experiencing joint pain so they can seek care and begin their journey towards returning to the activities they love.”

CT-based planning is an integral component of Mako SmartRobotics™ that allows surgeons to know more about their patient’s anatomy and the procedure prior to surgery.  Mako’s innovative AccuStop haptic technology enables surgeons to execute their plans with precision, helping to minimize tissue disruption. Mako SmartRobotics™ has demonstrated better outcomes, like less pain and quicker recovery times, compared to manual joint replacement surgery.

Also Read: Aidoc Introduces the First and Only AI-Powered Solution to Identify Suspected Posterior and Anterior Large and Medium Vessel Occlusions

Additionally, by enabling products like Mako with digital capabilities, known as Advanced Digital Healthcare, Stryker is generating insights to drive improved clinical, operational and financial outcomes across the continuum of care.

The omnichannel “Scan. Plan. Mako Can.” campaign will come to life through different assets and various media channels, including linear TV, streaming TV, social media, YouTube, programmatic/endemic and paid search.

Those living with joint pain are encouraged to speak with their healthcare professional about available treatment plans and whether joint replacement surgery is right for them. More information about Mako SmartRobotics™ is available at MakoCan.com.

All surgery carries risk. Surgeons must rely on their own professional clinical judgment when deciding whether to utilize a particular technology when treating a patient in their own practice. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any technology before using it in surgery. Not all patients will have the same postoperative recovery and activity level. Individual results vary.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img